0001209191-23-025413.txt : 20230424
0001209191-23-025413.hdr.sgml : 20230424
20230424165111
ACCESSION NUMBER: 0001209191-23-025413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230421
FILED AS OF DATE: 20230424
DATE AS OF CHANGE: 20230424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: VIERLING JOHN
CENTRAL INDEX KEY: 0001191859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 23840695
MAIL ADDRESS:
STREET 1: 110 N GEORGE BURNS RD #D-4018
CITY: LOS ANGELES
STATE: MD
ZIP: 90048
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-04-21
0
0001300699
Athenex, Inc.
ATNX
0001191859
VIERLING JOHN
C/O ATHENEX, INC.
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
1
0
0
0
0
Common Stock
2023-04-21
4
A
0
6513
1.305
A
12329
D
Stock Option (Right to Buy)
241.20
2023-04-01
2029-04-01
Common Stock
500
500
D
Stock Option (Right to Buy)
229.80
2023-04-03
2029-04-03
Common Stock
125
125
D
Stock Option (Right to Buy)
249.00
2030-06-05
Common Stock
625
625
D
Stock Option (Right to Buy)
76.00
2022-08-03
2031-08-03
Common Stock
375
375
D
Stock Option (Right to Buy)
9.14
2032-06-28
Common Stock
875
875
D
Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase.
As of February 15, 2023, the issuer effected a reverse stock split of its common stock at a ratio of 1-for-20, resulting in every 20 shares owned by the reporting person to be combined into one share of common stock.
This option was adjusted to reflect the reverse stock split that occurred on February 15, 2023.
This option vests in four equal annual installments beginning on June 5, 2021.
This option vests on June 28, 2023.
/s/Staci Holquist, Attorney-in-Fact
2023-01-17